M06.38 identifies a rheumatoid nodule located at the vertebrae, classified under other rheumatoid arthritis without rheumatoid factor involvement as the primary driver.
Verified May 8, 2026 · 5 sources ↓
- Status
- Billable
- Chapter
- 13
- Related CPT
- 8
- Region
- Spine
Documentation tips
What should appear in the chart to support M06.38.
Source · Editorial brief grounded in 5 cited references ↓
- Explicitly name the vertebrae as the nodule site — 'rheumatoid nodule at the cervical/thoracic/lumbar vertebrae' — rather than generic spinal involvement.
- Document whether rheumatoid factor is positive or negative; this determines whether M05.x or M06.x is the appropriate parent category.
- Record imaging findings (MRI or CT) confirming the vertebral nodule location and size to support medical necessity for advanced imaging CPTs.
- Note any functional or neurological impact of the vertebral nodule, as these comorbidities influence MS-DRG tier assignment (MCC vs. CC vs. neither).
- If nodules are present at additional anatomic sites in the same encounter, document each site explicitly so the coder can evaluate M06.38 plus a peripheral site code versus M06.39 (multiple sites).
Related CPT procedures
Procedure codes commonly billed with M06.38. Linking the right diagnosis to the right procedure is what establishes medical necessity.
Source · CMS LCDs · AAOS specialty guidance · claims-pattern analysis
Common coding pitfalls
The recurring mistakes coders make with M06.38 and adjacent codes.
Source · Editorial brief grounded in CDC ICD-10-CM tabular guidance, AAOS coding references, and cited references ↓
- Defaulting to M06.30 (unspecified site) when the vertebral location is clearly documented — M06.38 is the correct billable code when the spine is specified.
- Confusing M06.38 (rheumatoid nodule, vertebrae) with M06.28 (rheumatoid bursitis, vertebrae) — nodule and bursitis are distinct subcategories under M06 and are not interchangeable.
- Using M06.39 (multiple sites) when only the vertebrae are documented — reserve multiple-sites codes for encounters where nodules at two or more distinct anatomic regions are explicitly noted.
- Failing to code underlying rheumatoid arthritis diagnosis separately when the clinical encounter addresses both the RA and the vertebral nodule as distinct problems — M06.38 does not capture the arthritis itself.
- Overlooking comorbidities that would shift the MS-DRG from 547 (no CC/MCC) to 546 or 545, which requires all relevant diagnoses to be coded and sequenced correctly.
Clinical context
Source · Editorial summary grounded in 5 cited references ↓
M06.38 is used when a patient with rheumatoid arthritis presents with a nodular lesion specifically at the vertebral column. Rheumatoid nodules at the spine are uncommon compared to peripheral sites such as the elbow or hand, but their vertebral location warrants precise site-specific coding rather than defaulting to M06.30 (unspecified site) or M06.39 (multiple sites).
This code sits within the M06.3x subcategory, which covers rheumatoid nodules by anatomic site. Unlike the M05.x codes, the M06.3x family does not presuppose seropositivity — M06.38 applies regardless of rheumatoid factor status. If nodules are also present at peripheral joints in the same encounter, consider whether M06.39 (multiple sites) better captures the full clinical picture, or whether separate site-specific codes are clinically warranted and supported by documentation.
M06.38 maps to MS-DRG v43.0 groups 545–547 (Connective tissue disorders with MCC, CC, or without CC/MCC), so the presence of complicating comorbidities documented in the same encounter directly affects DRG assignment and reimbursement tier. Ensure all relevant comorbidities are coded to maximize appropriate DRG capture.
Sibling codes
Other billable codes under M06.3 (laterality / anatomic variants).
Frequently asked questions
Source · Generated from the editorial pipeline, verified against 5 cited references ↓
01Does M06.38 require rheumatoid factor to be negative?
02When should I use M06.39 (multiple sites) instead of M06.38?
03Can M06.38 be the principal diagnosis, or should the underlying RA code lead?
04What is the difference between M06.28 and M06.38?
05How does M06.38 affect DRG assignment?
06Is a specific vertebral level (cervical, thoracic, lumbar) required for M06.38?
Sources & references
Editorial content was developed using the following public sources. Last verified May 8, 2026.
- 01CDC ICD-10-CM Tabular List 2026
- 02icd10data.comhttps://www.icd10data.com/ICD10CM/Codes/M00-M99/M05-M14/M06-/M06.38
- 03rheumatologyadvisor.comhttps://www.rheumatologyadvisor.com/diagnostic-update/rheumatology-icd-10-codes/
- 04aapc.comhttps://www.aapc.com/codes/icd-10-codes/M06.3
- 05cms.govhttps://www.cms.gov/medicare/coding/icd10/downloads/icd10clinicalconceptsorthopedics1.pdf
Mira AI Scribe
Mira's AI scribe captures the vertebral location of the rheumatoid nodule from clinical notes and imaging reports, along with rheumatoid factor status, any neurological or functional deficits caused by the lesion, and a list of active comorbidities. This specificity prevents a drop to the unspecified-site code M06.30 and ensures comorbidities are coded to the correct MS-DRG tier rather than defaulting to the no-CC/MCC group.
See how Mira captures M06.38 documentation